logo

For the Inventor, By the Inventor

Amherst, NY, United States of America

Joan E MacDiarmid

This inventor holds 2 USPTO granted patents. Top assignee: The State University of New York. Active years: 1985-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joan E MacDiarmid. Retrieved from https://idiyas.com/inventor/joan-e-macdiarmid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal2 out of 2,046 
 
The State University of New York
 patents

Years Active: 1985-1989

Loading Chart...
2 patents (USPTO):Explore Patents
1. 4886790 - Novel bis(2,2-dimethyl-1-aziridinyl) phosphinic amides for use in the (1989-12-12),
2. 4544501 - Bis(2,2-dimethyl-1-aziridinyl)phosphinic amides for use in the treatment (1985-10-01),

Title: Innovations of Joan E MacDiarmid

Introduction

Joan E MacDiarmid is a notable inventor based in Amherst, NY (US). She has made significant contributions to the field of antineoplastic agents, focusing on innovative methods to inhibit tumor cell replication. With a total of 2 patents, her work is recognized for its potential impact on cancer treatment.

Latest Patents

Her latest patents include the development of novel bis(2,2-dimethyl-1-aziridinyl) phosphinic amides. These compounds are designed for use in inhibiting the replication of tumor cells. The specific formula involves antineoplastic agents where R and R' can be hydrogen, alkyl, substituted alkyl, phenyl, or substituted phenyl. Additionally, the compounds feature Z as either oxygen or sulfur, showcasing her innovative approach to cancer therapy.

Career Highlights

Joan E MacDiarmid is affiliated with the State University of New York, where she continues her research and development in the field of pharmaceuticals. Her work has garnered attention for its scientific rigor and potential applications in medical treatments.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Michael E Perlman and Thomas J Bardos. These partnerships have contributed to the advancement of her research and the successful development of her patents.

Conclusion

Joan E MacDiarmid's contributions to the field of antineoplastic agents highlight her innovative spirit and dedication to improving cancer treatment. Her work continues to inspire future research and development in this critical area of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…